Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Enhanced Antitumor Efficacy with Combined Administration of Astragalus and Pterostilbene for Melanoma

  • Huang, Xin-Yan (Dermatology Department, Zhejiang University of Technology) ;
  • Zhang, Song-Zhao (Clinical Laboratory, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University of Technology) ;
  • Wang, Wen-Xi (College of Pharmaceutical Science, Zhejiang University of Technology)
  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Astragalus, a commonly used traditional Chinese medicine, has exhibited antitumor actions in patients. In this study, in vitro and in vivo antitumor effects of astragalus and synergistic antitumor efficacy in combination with pterostilbene were investigated. Melanoma cells were treated with pterostilbene (Pt), graduated doses of astragalus injection (AI), or these in combination. Cell viability was measured using a MTT assay. Released nucleosomes and caspase activity were measured using enzyme-linked immunosorbent assay. Growth inhibition in vitro and in vivo was also assessed. Analysis of variance and t tests were used for statistical analysis. Significant reduction (p<0.05) in cellular proliferation were observed with AI and AI-Pt in a time- and concentration-dependent manner. Apoptosis and caspase-3/7 activity were significantly increased by AI and AI-Pt treatment (p<0.05). In vivo, AI inhibited melanoma tumor growth, with inhibition rates ranging from 36.5 to 62.3%, by inducing apoptosis via up-regulation Bax expression and the Bax/Bcl-2 ratio and down-regulating Bcl-2 expression. AI significantly inhibits the growth of melanoma in vitro and in vivo by inducing apoptosis. These data suggest that combined treatment of astragalus with pterostilbene enhances antitumor efficacy.

Keywords

References

  1. Auyeung KK, Mok NL, Wong CM, Cho CH, Ko JK (2010). Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. Int J Mol Med, 26, 341-9.
  2. Auyeung KK, Woo PK, Law PC, Ko JK (2012). Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol, 141, 635-41. https://doi.org/10.1016/j.jep.2011.08.010
  3. Balch CM, Soong SJ, Gershenwald JE, et al (2001). Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol, 19, 3622-34.
  4. Bastiaannet E, Beukema JC, Hoekstra HJ (2005). Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev, 31, 18-26. https://doi.org/10.1016/j.ctrv.2004.09.005
  5. Chapman PB, Hauschild A, Robert C, et al (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med, 364, 2507-16. https://doi.org/10.1056/NEJMoa1103782
  6. Chen HW, Lin IH, Chen YJ, et al (2012). A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: A phase II double-blind, randomized placebo-controlled study. Clin Invest Med, 35, E1-11.
  7. Cho WC, Leung KN (2007). In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett, 252, 43-54. https://doi.org/10.1016/j.canlet.2006.12.001
  8. Cui R, He J, Wang B, Zhang F, et al (2003). Suppressive effect of Astragalus membranaceus Bunge on chemical hepatocarcinogenesis in rats. Cancer Chemother Pharmacol, 51, 75-80. https://doi.org/10.1007/s00280-002-0532-5
  9. Dong JC, Dong XH (2005). Comparative study on effect of Astragalus injection and interleukin-2 in enhancing antitumor metastasis action of dendrite cells. Zhongguo Zhong Xi Yi Jie He Za Zhi, 25, 236-9.
  10. Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB (2013). A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res, 183, 645-53. https://doi.org/10.1016/j.jss.2013.02.037
  11. Ferrer P, Asensi M, Segarra R, et al (2005). Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia, 7, 37-47. https://doi.org/10.1593/neo.04337
  12. Guo L, Bai SP, Zhao L, Wang XH (2012). Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: Effects on quality of life and survival. Med Oncol, 29, 1656-62. https://doi.org/10.1007/s12032-011-0068-9
  13. Hodi FS, O'Day SJ, McDermott DF, et al (2010). Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med, 363, 711-23. https://doi.org/10.1056/NEJMoa1003466
  14. Hu YW, Liu CY, Du CM, et al (2009). Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. J Ethnopharmacol, 123, 293-301. https://doi.org/10.1016/j.jep.2009.03.016
  15. Johnson GE, Ivanov VN, Hei TK (2008). Radiaosensitiztion of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis, 13, 790-802. https://doi.org/10.1007/s10495-008-0212-y
  16. Khan N, Khan MK, Almasan A, Singh AD, Macklis R (2011). The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys, 80, 645-54. https://doi.org/10.1016/j.ijrobp.2010.12.071
  17. Li LK, Kuang WJ, Huang YF, et al (2012). Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo. Indian J Pharmacol, 44, 78-81. https://doi.org/10.4103/0253-7613.91872
  18. McCulloch M, See C, Shu XJ, et al (2006). Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: metaanalysis of randomized trials. J Clin Oncol, 24, 419-30. https://doi.org/10.1200/JCO.2005.03.6392
  19. McCormack D, McFadden D (2012). Pterostilbene and cancer: current review. J Surg Res, 173, e53-61. https://doi.org/10.1016/j.jss.2011.09.054
  20. McFadden D (2013). A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev, 575482.
  21. Na D, Liu FN, Miao ZF, Du ZM, Xu HM (2009). Astragalus extract inhibits destruction of gastric cancer cells to mesothelial cells by anti-apoptosis. World J Gastroenterol, 15, 570-7. https://doi.org/10.3748/wjg.15.570
  22. Nicholl MB, Elashoff D, Takeuchi H, Morton DL, Hoon DS (2011). Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients. Ann Surg, 253, 116-22. https://doi.org/10.1097/SLA.0b013e3181fca894
  23. Osmond GW, Augustine CK, Zipfel PA, Padussis J, Tyler DS (2012). Enhancing melanoma treatment with resveratrol. J Surg Res, 172, 109-15. https://doi.org/10.1016/j.jss.2010.07.033
  24. Remsberg CM, Yanez JA, Ohgami Y, et al (2007). Pharmacometrics of pterostilbene: Preclinical pharmacokinetics and metabolism, anticancer, anti-inflammatory, antioxidant, and analgesic activity. Phytother Res, 22, 169-79.
  25. Rimando AM, Cuendet M, Desmarchelier C, et al (2002). Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem, 50, 3453-7. https://doi.org/10.1021/jf0116855
  26. Rizvi I, Riggs DR, Jackson BJ, et al (2006). Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma. J Surg Res, 133, 3-6. https://doi.org/10.1016/j.jss.2006.02.023
  27. Santos FM, Latorre AO, Hueza IM, et al (2011). Increased antitumor efficacy by the combined administration of swainsonine and cisplatin in vivo. Phytomedicine, 18,1096-101. https://doi.org/10.1016/j.phymed.2011.06.005
  28. Schneider JG, Alosi JA, McDonald DE, McFadden DW (2009). Effects of pterostilbene on melanoma alone and in synergy with inositol hexaphosphate. Am J Surg, 198, 679-84. https://doi.org/10.1016/j.amjsurg.2009.07.014
  29. Schneider JG, Alosi JA, McDonald DE, McFadden DW (2010). Pterostilbene inhibits lung cancer through induction of apoptosis. J Surg Res, 161, 18-22. https://doi.org/10.1016/j.jss.2009.06.027
  30. Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
  31. Siwicka D, Skopinska-Rozewska E, Bodera P (2011). Immunotropic and anti-tumor effects of plant adaptogens. III. Astragalus (Fabaceae). Centr Eur J Immunol, 36, 104-7.
  32. Song Y, Yang J, Bai WL, Ji WY (2011). Anti-tumour and immunoregulatory effects of Astragalus on nasopharyngeal carcinoma In Vivo and In Vitro. Phytother Res, 25, 909-15. https://doi.org/10.1002/ptr.3354
  33. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-62. https://doi.org/10.1126/science.7878464
  34. Tolomeo M, Grimaudo S, Di Cristina A, et al (2005). Pterostilbene and 30-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol, 37, 1709-26. https://doi.org/10.1016/j.biocel.2005.03.004
  35. Treasure J (2005). Herbal medicine and cancer: an introductory overview. Semin Oncol Nurs, 21, 177-83. https://doi.org/10.1016/j.soncn.2005.04.006
  36. Villa AM, Berman B (2004). Immunomodulators for skin cancer. J Drugs Dermatol, 3, 533-9.
  37. Voller D, Ott C, Bosserhoff A (2013). MicroRNAs in malignant melanoma. Clin Biochem, 46, 909-17. https://doi.org/10.1016/j.clinbiochem.2013.01.008
  38. Wu P, Dugoua JJ, Eyawo O, Mills EJ (2009). Traditional Chinese medicines in the treatment of hepatocellular cancers: A systematic review and meta-analysis. J Exp Clin Cancer Res, 28, 112. https://doi.org/10.1186/1756-9966-28-112
  39. Zee-Cheng RK (1992). Shi-quan-da-bu-tang (ten significant tonic decoction), SQT.A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find Exp Clin Pharmacol, 14, 725-36.
  40. Zhang H, Xu Q, Krajewski S, Krajewska M, et al (2000). BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci USA, 97, 2597-602. https://doi.org/10.1073/pnas.97.6.2597

Cited by

  1. Effects of Hypobaric Conditions on Apoptosis Signalling Pathways in HeLa Cells vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.5043